A1309 cells were purposefully selected as they contain genetic alterations associated with early disease development that appear to synergize with SKP2 loss, as evidenced by the more pronounced CIN phenotypes in the preceding section. The gene discussed is SKP2; the disease is cervical squamous intraepithelial neoplasia.